SELLAS Life Sciences Group, Inc. SLS

Set alert

Price alert · SLS

All alert types
8.74 USD -0.95 -9.76%

As of Nov 2, 3:35 PM ET

Bid
8.73 × 19
Ask
8.74 × 5
8.48 Day range 9.72
1.39 52-week range 15.88
YTD
+131.70%
1 year
+379.95%
Open
9.70
Prev close
9.68
Mkt cap
1.76B
Vol
12.79M
Avg vol
6.67M
EPS
-0.21
P/E
0.00
Div yield
0.00%
More statistics
Low
8.48
High
9.72
Forward P/E
-93.40
Beta
2.57
Short ratio
10.31
Inst. own
36.98%
Dividend
0.00
Ex-div date
Earnings
Nov 18, 2026
50-d avg
12.23
200-d avg
8.54
1y target
32.50

MAX chart

Chart tools
Interval

Events in this range
  • Jan 1, 2018Split: 1 for 30
  • Jan 2, 2018Split: 1 for 30
  • Nov 6, 2019Split: 1 for 50
  • Sep 7, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
Signals (46)
NameDateAgo
SMA: BearishNov 2, 202625 minutes ago
SMA: BullishDec 1, 202511 months ago
SMA: BearishNov 1, 20251 year ago
SMA: BullishApr 1, 20251 year ago
SMA: BullishApr 1, 20251 year ago
SMA: BearishFeb 1, 20251 year ago
SMA: BullishJan 1, 20251 year ago
SMA: BearishNov 1, 20242 years ago
SMA: BullishApr 1, 20242 years ago
SMA: BearishFeb 1, 20233 years ago
SMA: BullishJan 1, 20233 years ago
SMA: BearishNov 1, 20224 years ago
SMA: BullishOct 1, 20224 years ago
SMA: BearishApr 1, 20224 years ago
SMA: BullishFeb 1, 20224 years ago
SMA: BearishDec 1, 20214 years ago
SMA: BearishOct 1, 20215 years ago
SMA: BullishAug 1, 20215 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BearishAug 1, 20206 years ago
SMA: BullishJul 1, 20206 years ago
MACD: Buy SignalJul 1, 20179 years ago
SMA: BearishJun 1, 201610 years ago
MACD: Sell SignalJun 1, 201610 years ago
MACD: Buy SignalMay 1, 201610 years ago
SMA: BullishApr 1, 201610 years ago
SMA: BearishNov 1, 201511 years ago
SMA: BullishSep 1, 201511 years ago
SMA: BearishJul 1, 201511 years ago
SMA: BullishJun 1, 201511 years ago
SMA: BearishAug 1, 201412 years ago
MACD: Sell SignalMay 1, 201412 years ago
SMA: BearishMar 1, 201412 years ago
RSI: OverboughtDec 1, 201312 years ago
SMA: BullishAug 1, 201313 years ago
SMA: BearishJul 1, 201313 years ago
SMA: BullishJan 1, 201313 years ago
SMA: BullishJan 1, 201313 years ago
SMA: BearishDec 1, 201213 years ago
SMA: BearishDec 1, 201213 years ago
SMA: BullishOct 1, 201214 years ago
SMA: BullishFeb 1, 201214 years ago
SMA: BearishDec 1, 201015 years ago
SMA: BullishNov 1, 201016 years ago
SMA: BearishJun 1, 201016 years ago
SMA: BullishDec 1, 200916 years ago

Financial health

Altman Z-Score

149.37 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -15.1×
FY 2016: -3.1×FY 2017: -0.7×FY 2018: -0.4×FY 2019: -0.4×FY 2020: -2.8×FY 2021: -4.1×FY 2022: -1.1×FY 2023: -0.8×FY 2024: -2.1×FY 2025: -15.1×
FY 2016 5y median -2.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 24.3×FY 2021: 11.3×FY 2022: 45.8×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 5.8×
FY 2016: 1.8×FY 2017: 8.5×FY 2018: 2.1×FY 2019: 1.2×FY 2020: 1.6×FY 2021: 4.2×FY 2022: 9.4×FY 2023: -3.7×FY 2024: 6.7×FY 2025: 5.8×
FY 2016 5y median 5.8× FY 2025
P/FCF -14.5×
FY 2016: -1.2×FY 2017: -1.6×FY 2018: -0.4×FY 2019: -0.4×FY 2020: -4.4×FY 2021: -3.3×FY 2022: -1.6×FY 2023: -0.8×FY 2024: -1.8×FY 2025: -14.5×
FY 2016 5y median -1.8× FY 2025
EV/EBITDA -12.7×
FY 2016: -3.2×FY 2017: -1.2×FY 2018: -0.8×FY 2019: 0.0×FY 2020: -0.7×FY 2021: -3.5×FY 2022: -0.9×FY 2023: 52.6×FY 2024: 80.3×FY 2025: -12.7×
FY 2016 5y median -0.9× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 6.2×FY 2021: 8.5×FY 2022: 29.6×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -6.9%
FY 2016: -85.8%FY 2017: -62.6%FY 2018: -282.7%FY 2019: -232.3%FY 2020: -22.6%FY 2021: -30.4%FY 2022: -61.8%FY 2023: -125.4%FY 2024: -55.6%FY 2025: -6.9%
FY 2016 5y median -55.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 97.4%FY 2022: 90.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -893.8%FY 2021: -332.8%FY 2022: -4195.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -881.9%FY 2021: -272.4%FY 2022: -4130.1%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -37.9%
FY 2016: -82.2%FY 2017: -1147.5%FY 2018: -527.6%FY 2019: -316.6%FY 2020: -59.9%FY 2021: -101.7%FY 2022: -851.4%FY 2023: 468.2%FY 2024: -326.3%FY 2025: -37.9%
FY 2016 5y median -101.7% FY 2025
ROIC -39.3%
FY 2016: -43.1%FY 2017: -90.7%FY 2018: -275.0%FY 2019: -173.0%FY 2020: -50.1%FY 2021: -115.5%FY 2022: -723.3%FY 2023: 535.6%FY 2024: -295.5%FY 2025: -39.3%
FY 2016 5y median -115.5% FY 2025
ROA -34.3%
FY 2016: -35.8%FY 2017: -70.9%FY 2018: -163.6%FY 2019: -116.2%FY 2020: -36.4%FY 2021: -78.3%FY 2022: -197.2%FY 2023: -600.4%FY 2024: -158.9%FY 2025: -34.3%
FY 2016 5y median -158.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 300.0%FY 2022: -86.8%FY 2023: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 10.3%
FY 2016: 53.3%FY 2017: 1.7%FY 2018: -101.0%FY 2019: 36.6%FY 2020: 15.3%FY 2021: -48.9%FY 2022: -65.8%FY 2023: 9.7%FY 2024: 16.8%FY 2025: 10.3%
FY 2016 FY 2025
EPS (diluted) 50.0%
FY 2016: -126.7%FY 2017: 44.1%FY 2018: 69.8%FY 2019: 93.1%FY 2020: 80.7%FY 2021: 36.5%FY 2022: -59.0%FY 2023: 37.1%FY 2024: 62.7%FY 2025: 50.0%
FY 2016 FY 2025
Free Cash Flow 19.8%
FY 2016: 7.0%FY 2017: 75.5%FY 2018: -176.8%FY 2019: 42.0%FY 2020: 41.0%FY 2021: -149.8%FY 2022: -8.8%FY 2023: -30.4%FY 2024: 4.1%FY 2025: 19.8%
FY 2016 FY 2025

Financial Health

Current Ratio 10.7×
FY 2016: 1.2×FY 2017: 0.5×FY 2018: 1.0×FY 2019: 1.6×FY 2020: 3.0×FY 2021: 4.6×FY 2022: 1.1×FY 2023: 0.2×FY 2024: 1.7×FY 2025: 10.7×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 10.7×
FY 2016: 1.2×FY 2017: 0.5×FY 2018: 1.0×FY 2019: 1.6×FY 2020: 3.0×FY 2021: 4.6×FY 2022: 1.1×FY 2023: 0.2×FY 2024: 1.7×FY 2025: 10.7×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.6×FY 2017: 5.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.2×FY 2023: -0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.6×
FY 2016: 0.1×FY 2017: -0.4×FY 2018: 0.8×FY 2019: 0.0×FY 2020: 2.1×FY 2021: 1.1×FY 2022: 0.5×FY 2023: -3.1×FY 2024: -20.4×FY 2025: 2.6×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: -4.6×FY 2017: -34.0×FY 2018: -119×FY 2019: -170×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 3.8%FY 2018: 4.5%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -2.8%FY 2018: -1.8%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31